← Leaderboards
Wuqiang Zhu
Mayo Clinic Arizona
$6,841,350
Attributed
$8,968,383
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,968,383 · 6
By mechanism
R01$8,597,133 · 5
R56$371,250 · 1
Top collaborators
- Jingwei Xie3 shared
- Mehdi Nikkhah2 shared
- Shu Wang1 shared
Others in their field
Other Emerging Leaders on “Cardiac”
- Ionut Bebu · George Washington University$14,731,026
- Barbara Halina Braffett · George Washington University$14,731,026
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Romergryko Geocadin · University Of Michigan At Ann Arbor$9,719,654
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- Nobuyuki Ishibashi · Children'S Research Institute$9,208,869
Research focus
CardiacCellsCardiac MyocytesHeartMyocardial InfarctionCardiac RegenerationNatural RegenerationMyocardial IschemiaMyocardialFamily SuidaeMyocardiumMediatingCell CycleCell SurvivalMouse ModelChronicOverexpressionAnimal ModelHeart FunctionExhibitsCicatrixInfarctionEngineeringInjured
Grant awards (15)
Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair$724,543
R01 · FY2025 · HL · contact PI
Programmed Cell Death 4 in Doxorubicin-Induced Cardiotoxicity$695,997
R01 · FY2025 · HL · contact PI
Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium$673,130
R01 · FY2025 · HL · contact PI
Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals$668,014
R01 · FY2025 · HL · contact PI
Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair$710,051
R01 · FY2024 · HL · contact PI
Electrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured Myocardium$688,146
R01 · FY2024 · HL · contact PI
Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals$654,653
R01 · FY2024 · HL · contact PI
Strategies to Enhance Engineered Heart Tissue Based Myocardial Repair$762,200
R01 · FY2023 · HL · contact PI
Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals$668,014
R01 · FY2023 · HL · contact PI
Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large Mammals$684,514
R01 · FY2022 · HL · contact PI
Myocardial Repair with a Novel Engineered Cardiac Muscle Patch$412,843
R01 · FY2022 · HL · contact PI
Myocardial Repair with a Novel Engineered Cardiac Muscle Patch$412,843
R01 · FY2021 · HL · contact PI
Myocardial Repair with a Novel Engineered Cardiac Muscle Patch$417,262
R01 · FY2020 · HL · contact PI
Myocardial Repair with a Novel Engineered Cardiac Muscle Patch$424,923
R01 · FY2019 · HL · contact PI
Myocardial Repair with a Novel Engineered Cardiac Muscle Patch$371,250
R56 · FY2018 · HL · contact PI